A Study of the Safety and Tolerability of MEDI-551 in Scleroderma

NCT00946699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma

Interventions

BIOLOGICAL: MEDI-551
BIOLOGICAL: Placebo
BIOLOGICAL: MEDI-551
BIOLOGICAL: MEDI-551
BIOLOGICAL: MEDI-551
OTHER: Placebo

Sponsor

MedImmune LLC